Fox Valley Clinical Research Center, Llc

Aurora, Illinois 60506-1400

0 studies enrolling now · 12 studies all time

What they study most

Atrial Fibrillation, Atrial Flutter, COVID-19, Cardiomyopathy, Chronic Heart Failure With Preserved Ejection Fraction, Diabetes, Type 1, Diabetes, Type 2, Heart Failure, Heart Failure With Preserved Ejection Fraction, Hypercholesterolemia, Myocardial Infarction, Myocardial Ischemia

Studies at this site

• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction — Recruiting now
• COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 — Stopped early
• Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed
• RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism — Completed
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Guiding Evidence Based Therapy Using Biomarker Intensified Treatment — Stopped early
• Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin — Completed
• Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes — Completed
• Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging — Completed
• Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation — Status unconfirmed